Stay updated with breaking news from Independent Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
05.08.2022 - Conference Call and Webcast Today at 8:30 a.m. ET Dosing patients in U.S. Phase 2/3 COVAXIN (BBV152) clinical trialCompleted dosing of patients in Cohort 1 of OCU400 gene therapy product candidateExpanding product pipeline with the regenerative ...
Independent Data and Safety Monitoring Committee Recommends Continuing Study Without Sample Size Adjustment IDSMC Did Not Identify Any Safety ConcernsPhase 2 Study Target Enrollment Achieved; Final Data and Communication Expected in October 2023Conference Call and Webcast Today at 2:00 p.m. PDT/5:00 p.m. EDTSOUTH...
Screened approximately 700 subjects and expanding to Eastern Europe, including Turkey, as part of its clinical diversification plans to support global...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
.jpg)
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires